HTG Molecular Diagnostics Stock News

In a report released today, Yi Chen from H.C. Wainwright upgraded Stealth Biotherapeutics (MITO) to Buy, with a price target of $5.00. The company's

In a report released today, Yi Chen from H.C. Wainwright upgraded Stealth Biotherapeutics ( MITO – Research Report ) to Buy , with a price target of $5.00 . The company’s shares closed last Thursd

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA (OBSV), AC Immune SA (ACIU) and Co-Diagnostics

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA

One thing we could say about the analysts on HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) - they aren't optimistic...

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cassiopea SpA (CPPSF), Oragenics (OGEN) and CytomX

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cassiopea SpA ( CPPSF – Research Report ), Oragenics ( OGEN – Research Report ) and CytomX Therapeu

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IntelGenx Technologies (IGXT), Aerpio Pharmaceuticals

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IntelGenx Technologies ( IGXT – Research Report ), Aerpio Pharmaceuticals ( ARPO – Research Report

Q4 2019 HTG Molecular Diagnostics Inc Earnings Call

Gainers • BioSig Technologies, Inc. (NASDAQ:BSGM) stock increased by 36.43% to $5.28 during Thursday's pre-market session. • Cerecor, Inc. (NASDAQ:CERC) stock moved...

Increased product and product-related services revenue over prior year, benefitting from expanded menu of profiling assays and increased number of customers adopting technology.

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25,

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 24) * BELLUS Health Inc (NASDAQ: BLU) * Global Cord

Stocks Analysis by Zacks Investment Research covering: S&P 500, Dow Jones Industrial Average, Gilead Sciences Inc, Biogen Inc. Read Zacks Investment Research's latest article on Investing.com